Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

Jianxin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5988-1883; OpenAlex author ID A5100438343. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 6

  1. Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden. Co-author DOI 10.3389/fonc.2023.1118633↗
  2. Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Co-author DOI 10.1016/j.canlet.2022.215722↗
  3. Identification of 2 Chinese Primary Pancreatic Ductal Adenocarcinoma Cancer Cell Lines and Their Phenotypes. Co-author DOI 10.1097/mpa.0000000000001932↗
  4. Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer. Co-author DOI 10.1016/j.pan.2020.02.008↗
  5. B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma. First author DOI 10.1111/cas.13914↗
  6. Gemcitabine enhances OSI-027 cytotoxicity by upregulation of miR-663a in pancreatic ductal adenocarcinoma cells. First author PMID 30788003↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingbo Liang · 5 shared papers, 2019–2023 · strength 0.64
  2. Qi Zhang · 3 shared papers, 2020–2023 · strength 0.45
  3. Qihan Fu · 2 shared papers, 2021–2023 · strength 0.34
  4. Xueli Bai · 2 shared papers, 2020–2021 · strength 0.23
  5. Mengyao Dai · 1 shared paper, 2023 · strength 0.22
  6. Brian T. Herbst · 1 shared paper, 2022 · strength 0.12
  7. Stephen T. Muth · 1 shared paper, 2022 · strength 0.12
  8. Nan Niu · 1 shared paper, 2022 · strength 0.12
  9. Junke Wang · 1 shared paper, 2022 · strength 0.12
  10. Keyu Li · 1 shared paper, 2022 · strength 0.12
  11. Pan Li · 1 shared paper, 2022 · strength 0.12
  12. Noah S Rozich · 1 shared paper, 2022 · strength 0.12
  13. Barish H. Edil · 1 shared paper, 2022 · strength 0.12
  14. Yao Xu · 1 shared paper, 2022 · strength 0.12
  15. Tingbo Liang · 1 shared paper, 2022 · strength 0.12
  16. Christopher L. Wolfgang · 1 shared paper, 2022 · strength 0.12
  17. Lei Zheng · 1 shared paper, 2022 · strength 0.12
  18. Arsen Osipov · 1 shared paper, 2022 · strength 0.12
  19. Qi Chen · 1 shared paper, 2020 · strength 0.11
  20. Tao Wei · 1 shared paper, 2020 · strength 0.11
  21. Jin Li · 1 shared paper, 2020 · strength 0.11
  22. Qi Chen · 1 shared paper, 2019 · strength 0.10
  23. Tao Wei · 1 shared paper, 2019 · strength 0.10
  24. Qi Zhang · 1 shared paper, 2019 · strength 0.10
  25. Xueli Bai · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.